JANX250516P22500
- 0.40
- 0.000.00%
Janux Therapeutics Newsroom
Here's Why We're Not At All Concerned With Janux Therapeutics' (NASDAQ:JANX) Cash Burn Situation
We're Interested To See How Janux Therapeutics (NASDAQ:JANX) Uses Its Cash Hoard To Grow
JonesTrading Maintains Janux Therapeutics(JANX.US) With Buy Rating, Cuts Target Price to $90
WEX, Lamb Weston, and More Stocks See Action From Activist Investors -- Barrons.com
Buy Rating for Janux Therapeutics: Promising Technology and Strong Financial Position Amid Competitive Pressure
Ra Capital Management Buys $25.3 Million in Janux Therapeutics Stock
Janux Therapeutics(JANX.US) 10% Shareholder Buys US$25.34 Million in Common Stock
Analysts' Top Healthcare Picks: Xenon (XENE), Janux Therapeutics Inc (JANX)
Janux Therapeutics, Inc. (JANX): Among The Stocks With At Least $30 Million In Insider Spending Recently
H.C. Wainwright Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $70
Janux Therapeutics Price Target Maintained With a $70.00/Share by HC Wainwright & Co.
Janux Therapeutics Price Target Lowered to $41 From $62 at Scotiabank
A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $41 to $200
Janux Therapeutics Reports Strong Financial Position and Clinical Progress
Janux Therapeutics Is Maintained at Sector Perform by Scotiabank
Janux Therapeutics Analyst Ratings
Wedbush Adjusts Price Target on Janux Therapeutics to $76 From $75, Maintains Outperform Rating
Promising Potential of Janux Therapeutics' Lead Asset and Strategic Plans Justify Buy Rating
Stifel Nicolaus Sticks to Their Buy Rating for Janux Therapeutics Inc (JANX)
Express News | Janux Therapeutics Inc : Scotiabank Cuts Target Price to $41.00 From $62.00